Example: Heart Attack

Clinical Trials on Adenovirus Infections, Human

Total 38 results

NCT04285788

Completed

Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients

Conditions: Adenovirus Infections, Human
NCT01113346

Unknown status

A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis

Conditions: Viral Gastroenteritis
NCT03790059

Recruiting

Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.

Conditions: Hepatocellular Carcinoma
NCT02276820

Withdrawn

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Conditions: Adenovirus Infection
NCT01869088

Unknown status

TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma
NCT02283489

Unknown status

Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

Conditions: Head and Neck Neoplasms
NCT03610581

Active, not recruiting

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Conditions: Human Papillomavirus Infections
NCT02579564

Unknown status

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Conditions: Malignant Hydrothorax; Non Small Cell Lung Cancer
NCT02702427

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation

Conditions: Cytomegalovirus Infection; Adenovirus Infection
NCT02919306

Completed

Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults

Conditions: Human Immunodeficiency Virus
NCT00755703

Completed

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Conditions: Influenza A Subtype H5N1 Infection
NCT00583024

Active, not recruiting

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer

Conditions: Hormone Refractory Prostate Cancer
NCT00583752

Active, not recruiting

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21

Conditions: Recurrent Prostate Cancer
NCT01006798

Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Conditions: Bird Flu; Influenza
NCT02575456

Completed

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Conditions: Ebola Disease
NCT03740256

Not yet recruiting

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Conditions: Bladder Cancer; Head and Neck Squamous Cell Carcinoma; Cancer of the Salivary Gland; Lung Cancer; Breast Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; Pancreatic Adenocarcinoma; Solid Tumor
NCT03964415

Recruiting

A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals

Conditions: Healthy
NCT00865566

Terminated

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Conditions: HIV Infections
NCT01972737

Completed

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

Conditions: Colon Cancer
NCT03896568

Recruiting

Oncolytic Adenovirus DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Conditions: IDH1 wt Allele; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma; Recurrent Gliosarcoma; Recurrent Malignant Glioma
NCT03780049

Recruiting

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Conditions: Hepatocellular Carcinoma
NCT01769170

Completed

A Study of the Safety and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients

Conditions: CMV; Adenoviruses (AdV); Epstein-Barr (EBV); Human Herpes Virus Type 6 (HHV6); BK Virus (BKV)
NCT00262327

Unknown status

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Conditions: Advanced Solid Tumor
NCT04097002

Recruiting

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

Conditions: Adenocarcinoma of the Prostate
NCT03341754

Completed

Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults

Conditions: Malaria